QGel
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info
Reproducing
HUMAN PHYSIOLOGY
Request Info

Biologically relevant scalable solutions for drug discovery and diagnostics

QGEL is a revolutionary synthetic and tunable extracellular matrix (ECM) technology that enables the growth of human tissues in a laboratory environment. It provides biologically relevant and scalable solutions for drug discovery and diagnostic applications. Oncology drug development scientists turn to QGel when seeking a biodynamic synthetic ECM capable of recapitulating complex in vivo features in an in vitro platform.

QGel Innovation

QGel Innovation

Where in vivo science
meets in vitro innovation.

QGel Innovation

QGel Assays

Assays

QGel's approach to
Physiological Relevance.

QGel Assays

QGel Products

Products

QGel® Assay Kits made
for workflow integration.

QGel Products

Targets and the Microenvironment

Cancer and the Tumor Microenvironment (TME)

More Info

Follow Us




Updates

VIDEO - Le Temps interview QGel CEO

VIDEO - @ s’intéresse à @ & la culture de  en 3D contre le 

May 31, 2016

More Info


L’Agefi highlights QGel in interview with CEO

.@ souligne le rôle de @ pour les tests de et le développement de meilleurs  http://bit.ly/1W1XI2l

May 18, 2016

More Info

QGel SA
Innovation Park
EPFL Building G
1015 Lausanne, Switzerland
T +41 21 694 0707
F +41 21 560 4957

Print Directions
Google Maps

Innovating Drug Discovery
QGel enables drug development in a laboratory environment that accurately and reliably mimics the functioning of human organs, which means greater predictability of drug efficacy before the clinical phase. With an improved understanding of a drug’s potential, researchers spend more time and resources on the most promising therapies.

Innovating Diagnostics
QGel diagnostic tools test drug efficacy directly on tumor cells reproduced from biopsy, which means patients gain access to therapies tailored specifically to their disease. QGel advances patient outcomes, promoting personalised and accelerated treatments in an economically sustainable way.

Contact us

Sitemap | Privacy Policy | Legal Notice
© 2015 QGel SA, Lausanne, Switzerland
  • QGel on Twitter
  • QGel on LinkedIn
  • QGel on Vimeo
Unless otherwise specified, all product names appearing in this website are trademarks owned by or licensed to QGel Inc. Unauthorized use is prohibited.